Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kura Oncology

6.18
+0.28004.75%
Post-market: 6.180.00000.00%17:20 EDT
Volume:829.35K
Turnover:5.13M
Market Cap:499.07M
PE:-3.06
High:6.30
Open:5.84
Low:5.78
Close:5.90
Loading ...

Q4 2024 Kura Oncology Inc Earnings Call

Thomson Reuters StreetEvents
·
28 Feb

Bullish Outlook for Kura Oncology: Buy Rating Affirmed Amid Optimism for Ziftomenib Approval and Competitive Advantage

TIPRANKS
·
27 Feb

Kura Oncology’s Promising Pipeline and Strategic Focus Justify Buy Rating

TIPRANKS
·
27 Feb

Kura Oncology Inc (KURA) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Growth

GuruFocus.com
·
27 Feb

Kura Oncology’s Promising Path to FDA Approval: Analyst Recommends ‘Buy’ Following Positive Phase II Results and Strategic Advancements

TIPRANKS
·
27 Feb

Kura Oncology’s Strategic Advancements and Financial Health Drive Buy Rating

TIPRANKS
·
27 Feb

Kura Oncology (KURA) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
27 Feb

Kura Oncology Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Stock Track | Kura Oncology Soars 6.69% After-Hours on Positive Q4 Results and Clinical Trial Updates

Stock Track
·
27 Feb

Kura Oncology: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

Kura Oncology Q4 GAAP EPS $(0.22) Beats $(0.65) Estimate, Sales $53.88M Beat $8.50M Estimate

Benzinga
·
27 Feb

BRIEF-Kura Oncology Q4 Operating Expenses USD 76.338 Million

Reuters
·
27 Feb

Analysts Are Bullish on Top Healthcare Stocks: Zimmer Biomet Holdings (ZBH), Kura Oncology (KURA)

TIPRANKS
·
07 Feb

BRIEF-Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
07 Feb

Kura Oncology reports inducement grants under Nasdaq listing rule

TIPRANKS
·
07 Feb

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
07 Feb

Kura Oncology Price Target Maintained With a $28.00/Share by JMP Securities

Dow Jones
·
07 Feb

Wedbush Adjusts Kura Oncology's Price Target to $26 From $34, Maintains Outperform Rating

MT Newswires Live
·
06 Feb

Kura Oncology Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
06 Feb

Kura Oncology drops 11% to $8.07 after leukemia update, BTIG downgrade

TIPRANKS
·
06 Feb